As traditional pharma markets begin to stagnate in the face an almost inevitable fall in sales caused key patents expire across the EU and US, it is the emerging markets that companies should be looking to as the future of development in pharmaceuticals. Which vastly less marketing, research and clinical trial costs, what is stopping us all setting up camp in China, India, Argentina or South Africa? The problem is that traditionally these markets have been hard to settle down in, often due to a lack of market knowledge and inaccurate forecasting.
Interested in market access? Then why not attend the worlds largest pharma access conference: Pharma Pricing & Market Access Outlook Europe? The event, taking place in London from the 24th to the 26th of February, brings together experts and professionals in the fields of market access and reimbursement from across the world. To learn more about speakers, networking opportunities, and to download a brochure, click here.